Observational study on relapsing polychondritis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on relapsing polychondritis (RP), a rare systemic inflammatory disease that causes recurrent inflammation of cartilage and can affect various organ systems. The research aims to understand the pathogenesis of RP through a longitudinal cohort approach, involving regular study visits every six months or annually. Participants will undergo blood and urine collection, physical exams, and complete questionnaires to assess disease activity and health status, which will help generate insights into the disease's mechanisms and potential new diagnostic and treatment strategies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 1\. Any subject considered to have a diagnosis of relapsing polychondritis according to the investigator.

Exclusion Criteria:

* 1\. Inability to provide consent, or in the case of minors, assent.

Where it's running

• University of Pennsylvania
  Philadelphia, Pennsylvania, United States Recruiting

Study contacts

• Principal investigator: Shubhasree Banerjee, MD — University of Pennsylvania
• Study coordinator: Carol McAlear
• Email: cmcalear@upenn.edu
• Phone: 7813214567

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ocular Symptoms in ANCA-Associated Vasculitis

  This study tests ocular changes in adults with GPA, MPA, or related vasculitis to see how the eyes are involved.

  Recruiting Military Institute od Medicine National Research Institute · Warsaw · NCT07664709

• Systemic Vasculitis Prognosis and Outcome

  This study follows patients suspected or diagnosed with systemic vasculitis over 10 years to see how their disease progresses and what factors predict outcomes.

  Recruiting Fondazione IRCCS Policlinico San Matteo di Pavia · Pavia, Pavia · NCT07586137

• Reducing unnecessary medications in older adults with rheumatic conditions

  This project will test whether giving doctors individualized MedSafer reports plus patient EMPOWER brochures helps people 60+ with rheumatic conditions who take five or more regular medications stop or reduce risky medicines.

  Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT07278609

• Comparing five immunomodulatory treatments for relapsing polychondritis

  This project will try commonly used immune-suppressing medicines to see which best controls mild-to-moderate relapsing polychondritis.

  Recruiting Phase 2 University of Pennsylvania · Philadelphia, Pennsylvania · NCT06941376

• Evaluating Upadacitinib for treating relapsing polychondritis

  This study is testing if a new medication called Upadacitinib can help adults with relapsing polychondritis feel better compared to standard treatments like steroids and immunosuppressants.

  Recruiting Phase 1/2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT06873100

• Inventory of vocal cord lesions causing dysphonia in autoimmune disease patients

  This study looks at the types of vocal cord problems that cause voice issues in people with autoimmune diseases to help improve their diagnosis and treatment.

  Recruiting University Hospital, Brest · Brest · NCT06779799

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.